LLY compared with PCRX: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

PCRXPacira BioSciences, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

PCRXPacira BioSciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

PCRX

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.3%▼−9.96%×1.08

Q1 FY26±10.0%▼−4.12%×0.41

= impliedLLY realized, solidPCRX realized, hatchedOne scale, both sides: full bar = 16%× = |realized| ÷ impliedSource: market data

Feb 27 '26

±11.0%

▼−3.01%

×0.27

Jan 9 '26±15.8%▼−9.57%×0.61

LLYELI Lilly & Co

1,371.32· pre 1,345.42· delayed

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

PCRXPacira BioSciences, Inc.

36.43· pre 36.43· delayed

Pre-marketNov 6 '26delayed

Mkt cap$1.5BRevenue$177MQ3 FY26Revenue$726MFY25

Compare

Pre-marketNov 6 '26delayed

LLYELI Lilly & Co

PCRXPacira BioSciences, Inc.

1,371.32pre 1,345.42delayed

Price

36.43pre 36.43delayed

$1.2T

Mkt cap

$1.5B

Q3 FY26$24.4B

Revenue

$177MQ3 FY26

FY25$65.2B

Revenue

$726MFY25

LLY1,371.32vsPCRX36.43Pre-marketNov 6 '26delayed